MannKind Corporation
30930 Russell Ranch Road
Suite 301
Westlake Village
California
91362
United States
Website: http://www.mannkindcorp.com/
399 articles about MannKind Corporation
-
MannKind Corporation Announces Positive New Market Survey Information Regarding AFRESA(R)
7/15/2009
-
MannKind Corporation Unveils Next-Generation Inhalation System
6/8/2009
-
MannKind Corporation to Present at the Needham Life Sciences Conference
6/3/2009
-
Emisphere Technologies, Inc. Receives Milestone Payment from MannKind Corporation
5/21/2009
-
FDA Accepts MannKind Corporation's Submission and Files NDA for AFRESA
5/18/2009
-
MannKind Corporation to Present at the Canaccord Adams Diabetes and Obesity Conference
5/5/2009
-
MannKind Corporation Reports First Quarter of 2009 Financial Results
5/4/2009
-
MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 4, 2009
4/27/2009
-
MannKind Corporation Submits NDA for AFRESA for Treatment of Diabetes
3/17/2009
-
MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on February 17, 2009
2/12/2009
-
MannKind Corporation Reports Successful Completion of Device Bioequivalence Trial
1/14/2009
-
SemBioSys Genetics Inc. Receives US$2.5 Million from Option Agreement with MannKind Corporation for Plant-Produced Insulin
1/6/2009
-
MannKind Corporation Reports Top-Line Results from Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
12/18/2008
-
MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
12/16/2008
-
MannKind Corporation's Two Phase 3 Studies Meet Goal
12/4/2008
-
MannKind Corporation Reports Third Quarter Financial Results - Conference Call Today at 9:00 a.m. EST -
11/5/2008
-
MannKind Corporation Opens $114 Million Production Plant in Connecticut
9/17/2008
-
MannKind Corporation (JOBS) Reports Positive Data from a Phase 3 Clinical Study of Technosphere Insulin in Type 1 Diabetes Study 009 Meets Its Primary Endpoint
9/16/2008
-
MannKind Corporation (JOBS) and Pfizer Inc. (JOBS) Announce Collaboration for Certain Exubera Patients to Transition to MannKind's Inhaled Insulin Therapy
9/16/2008
-
MannKind Corporation to Host Webcast Analyst Day September 16, 2008 Company To Review Data from First Pivotal Phase 3 Clinical Trial
9/11/2008